Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11987810 RPE cell populations and methods of generating same

Patent 11987810 was granted and assigned to Cell Cure Neurosciences on May, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Cell Cure Neurosciences

0

Current Assignee

Cell Cure Neurosciences

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Ofer Wiser0

Osnat Bohana-Kashtan0

Lior Ann Rosenberg Belmaker0

Date of Patent

May 21, 2024

0

Patent Application Number

175460130

Date Filed

December 8, 2021

0

Patent Citations

US Patent 9446076 Pharmaceutical composition for the treatment of heart diseases

0

US Patent 6921633 Methods and compositions for the preservation of cells, tissues or organs in the vitreous state

0

US Patent 8268303 Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration

0

US Patent 8956866 Retinal pigment epithelial cells differentiated from embryonic stem cells with nicotinamide and activin A

0

US Patent 11066642 Preparation of retinal pigment epithelium cells

0

Patent Primary Examiner

0

Patent abstract

A population of human polygonal RPE cells is disclosed. At least 95% of the cells thereof co-express premelanosome protein (PMEL17) and cellular retinaldehyde binding protein (CRALBP), wherein the trans-epithelial electrical resistance of the cells is greater than 100 ohms. Methods of generating same are also disclosed.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11987810 RPE cell populations and methods of generating same

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool